UF-021

· R-Tech Ueno, Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UF-021, covering 2016-01-29 to 2016-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa [Phase 3]